Asthma Awareness Worked. But It May Be Focusing on the Wrong Stage of Disease

By Doanh Nguyen, MD FAAAAI, 04/30/2026

A quiet problem hiding in plain sight

Every May, public health campaigns across the United States mark Asthma Awareness Month, a decades-long effort launched by the National Heart, Lung, and Blood Institute and supported by groups like the American Lung Association and the Asthma and Allergy Foundation of America.

The message has been consistent: asthma is common, serious, and treatable. And by many measures, that message has worked. Death rates have fallen. Treatments have improved. Millions now recognize wheezing, chest tightness, and shortness of breath as signs of a manageable condition rather than an inevitable crisis. But there is a deeper question worth asking:

What if we’ve become very good at recognizing asthma only after it has already progressed?

The illusion of “sudden” asthma

To most people, asthma appears suddenly, an attack, a flare, a moment when breathing becomes difficult. Medicine has largely followed that same script. Diagnosis typically begins when symptoms become obvious and measurable, often confirmed by breathing tests that detect airflow limitation. Yet this model may be misleading.

The lungs are surprisingly quiet organs in the early stages of disease. Unlike the heart or the skin, they do not readily signal distress. Inflammation can build gradually, subtly altering airway behavior long before a person notices classic symptoms. By the time breathing tests show abnormalities, the underlying process may have been unfolding for years.

When the body whispers instead of shouts

If early asthma does not announce itself with wheezing, how does it appear? Increasingly, clinicians are noticing patterns that don’t fit the traditional mold. Patients may report:

Unexplained fatigue or reduced stamina
Difficulty concentrating or “brain fog”
Episodes of rapid heartbeat or anxiety-like sensations
Exercise intolerance, often dismissed as deconditioning

These symptoms are rarely linked to the lungs. They are more often attributed to stress, lifestyle, or unrelated conditions. Yet they may reflect subtle instability in airway function, an early phase of inflammation that has not yet crossed the threshold of diagnosis. In this light, asthma may be less of a sudden disease and more of a slow, systemic drift toward instability.

A broader view: asthma beyond the lungs

Traditionally, asthma has been defined as a disease of the airways. But the immune system does not respect organ boundaries. The same inflammatory signals active in the lungs can influence other tissues throughout the body. Researchers and clinicians are beginning to explore links between airway inflammation and:

Digestive disturbances resembling irritable bowel syndrome
Irritation in other epithelial tissues, such as the bladder
Early markers of autoimmune activity
Stress hormone activation that affects heart rate and energy levels

These connections are still being investigated, but they point toward a more integrated view of asthma, not simply as a localized breathing disorder, but as part of a wider network of immune and epithelial responses.

Why we still diagnose asthma late

If early disease exists, why don’t we detect it?

Part of the answer lies in how medicine defines illness. Diagnostic systems are designed to be precise, often requiring clear, measurable abnormalities. In asthma, that typically means demonstrable airflow limitation. Guidelines such as those from the Global Initiative for Asthma have improved care by standardizing treatment. But they also reinforce a threshold: no measurable impairment, no diagnosis.

There are practical barriers as well. Lung function tests require effort and coordination. Biomarkers of inflammation exist, but they are not widely used as screening tools. And unlike blood pressure or blood sugar, there is no routine check for “lung health” during standard medical visits. The result is a system that is highly effective at treating established disease, but less equipped to detect its earliest stages.

Rethinking awareness

Asthma Awareness Month has helped transform outcomes for people with severe and symptomatic disease. That is a genuine success. But awareness, as it stands today, is largely focused on recognizing when something has already gone wrong.

The next step may require a shift in perspective. What if awareness campaigns emphasized not just attacks, but early warning signs? What if routine care included simple ways to assess airway stability before symptoms escalate? What if asthma were understood not as an intermittent problem, but as a continuous process that can be identified and managed earlier?

Such changes would move asthma care closer to the preventive models used for other chronic conditions, catching disease before it disrupts daily life.

A different kind of awareness

In many ways, Asthma Awareness Month has done exactly what it set out to do: it made asthma visible. But visibility is not the same as understanding timing.

Today, the challenge is more subtle. It is not about recognizing asthma when breathing becomes difficult. It is about recognizing it when the body is still compensating, when symptoms are diffuse, easily dismissed, and not yet labeled.

The future of asthma awareness may depend on expanding the question from: “Do you have asthma?” to something more nuanced:“ How early in the process can we see it, and what happens if we look sooner?”

Reference:

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2024 Update.

2. Aaron SD, Vandemheen KL, FitzGerald JM, et al. Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma. JAMA. 2017;317(3):269-279. doi:10.1001/jama.2016.19627
3. Reza MI, Ambhore NS. Inflammation in Asthma: Mechanistic Insights and the Role of Biologics in Therapeutic Frontiers. Biomedicines. 2025;13(6):1342. Published 2025 May 30. doi:10.3390/biomedicines13061342
4. Stang J, Sikkeland LIB, Tufvesson E, Holm AM, Stensrud T, Carlsen KH. The Role of Airway Inflammation and Bronchial Hyperresponsiveness in Athlete's Asthma. Med Sci Sports Exerc. 2018;50(4):659-666. doi:10.1249/MSS.0000000000001478
5. Krempski JW, Dant C, Nadeau KC. The origins of allergy from a systems approach. Ann Allergy Asthma Immunol. 2020;125(5):507-516. doi:10.1016/j.anai.2020.07.013